Change Matters: Medication Change Prediction with Recurrent Residual Networks
read the original abstract
Deep learning is revolutionizing predictive healthcare, including recommending medications to patients with complex health conditions. Existing approaches focus on predicting all medications for the current visit, which often overlaps with medications from previous visits. A more clinically relevant task is to identify medication changes. In this paper, we propose a new recurrent residual network, named MICRON, for medication change prediction. MICRON takes the changes in patient health records as input and learns to update a hidden medication vector and the medication set recurrently with a reconstruction design. The medication vector is like the memory cell that encodes longitudinal information of medications. Unlike traditional methods that require the entire patient history for prediction, MICRON has a residual-based inference that allows for sequential updating based only on new patient features (e.g., new diagnoses in the recent visit) more efficiently. We evaluated MICRON on real inpatient and outpatient datasets. MICRON achieves 3.5% and 7.8% relative improvements over the best baseline in F1 score, respectively. MICRON also requires fewer parameters, which significantly reduces the training time to 38.3s per epoch with 1.5x speed-up.
This paper has not been read by Pith yet.
Forward citations
Cited by 2 Pith papers
-
RePrompT: Recurrent Prompt Tuning for Integrating Structured EHR Encoders with Large Language Models
RePrompT uses recurrent prompt tuning to inject prior-visit latent states and cohort-derived population prompt tokens into LLMs, yielding better performance than pure EHR or pure LLM baselines on MIMIC clinical predic...
-
Fine-grained List-wise Alignment for Generative Medication Recommendation
FLAME applies fine-grained list-wise alignment and Group Relative Policy Optimization to large language models for generating safe medication recommendations by sequentially adding or removing drugs.
discussion (0)
Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.